USRM Reaches Key Sales Milestone of Proprietary Adipocell TM Product
Company Poised to Be Industry Leader in Autologous Adipose Stem Cell Treatments SUNRISE, FL – Jan. 15, 2018 – U.S. Stem Cell, Inc. (OTC: USRM), a leader in the development…
USRM Stem Cell Treatment Shows Promise in Enhancing Erectile Function
World-Renowned Athlete Receives Treatment, Featured in Men’s Health Magazine SUNRISE, FL – Jan. 8, 2018 – U.S. Stem Cell, Inc. (OTC: USRM), a leader in the development of proprietary, physician-based…
USRM Responds to Lawsuit Filed for Discontinued Eye Treatments
MIAMI, FL –Dec.20, 2017 – U.S. Stem Cell, Inc. (OTC: USRM), a leader in the development of proprietary, physician-based stem cell therapies and novel regenerative medicine solutions, today responded to…
Degenerative Disc Patients Significantly Improve with USRM’s Adipocell TM Chief Scientific Officer to Present Data at IFATS
MIAMI, FL –Nov. 28, 2017 – U.S. Stem Cell, Inc. (OTC: USRM), a leader in the development of proprietary, physician-based stem cell therapies and novel regenerative medicine solutions, today announced…
U.S. Stem Cell Reports 3rd Q: Increases Revenue, Reduces Debt
Sunrise, FL – Nov. 7, 2017 – U.S. Stem Cell, Inc. (OTC: USRM), international leader in the development of proprietary, physician-based stem cell therapies and novel regenerative medicine, today announced…
U.S. Stem Cell, Inc. Announces Clinical Expansion in U.S. Market
Sunrise, FL – Nov. 1, 2017 – U.S. Stem Cell, Inc. (OTC: USRM), a leader in the development of proprietary, physician-based stem cell therapies and novel regenerative medicine solutions, today…
U.S. Stem Cell, Inc CEO Mike Tomas Honored As PACE Center For Girls Miami Pioneer By PACE Center For Girls Miami
Sunrise, FL – October 26, 2017 – U.S. Stem Cell, Inc. (OTC: USRM), a leader in the regenerative medicine, cellular therapy industry providing physician based stem cell therapies to human…
U.S. Stem Cell, Inc. Cso to Present at Bulletproof Biohacking Conference on October 13th in Pasadena, Ca
Sunrise, FL – October 10, 2017 – (OTC:USRM) U.S. Stem Cell, Inc., a Florida corporation and leader in novel regenerative medicine solutions and physician-based stem cell therapies for human and…
CEO Blog: September 2017 Update on Operations Post Irma, New Clinic Openings and Debt Reduction
Dear Shareholders and Friends, September is no doubt off to an exciting start—in part due to Hurricane Irma. Although many of our friends and family were not as fortunate and…
U.S. Stem Cell, Inc. Reports Debt Restructuring Agreement and Debt Reduction in Form 8-K
Sunrise, FL – September 13, 2017 – (OTC:USRM) U.S. Stem Cell, Inc., a Florida corporation and leader in novel regenerative medicine solutions and physician-based stem cell therapies for human and…
U.S. Stem Cell, Inc. Corporate Office, Lab and Clinic Remain Operational Post Hurricane Irma
Sunrise, FL – September 12, 2017 – (OTC:USRM) U.S. Stem Cell, Inc., a Florida corporation and leader in novel regenerative medicine solutions and physician-based stem cell therapies for human and…
CEO Blog: A Historic Quarter for USSC
10 August 2017 Dear Shareholders and Friends, It has been a historic quarter for us at U.S. Stem Cell Inc.! We achieved many milestones including expanding clinic operations, publishing research…